In experimental studies IgM antibodies targeting oxLDL are reported to have a protective role in atherosclerosis [9, 10] while in clinical studies there is an inverse association of anti-oxLDL IgM and cardiovascular disease [11, 12]. Here, CD40LG is linked to atherosclerosis.